OBJECTIVE: Because appropriate rectal cancer care and subsequent outcomes can be influenced by several variables, our objective was to investigate how race, ethnicity, and socioeconomic status (SES) may impact rectal cancer outcomes. BACKGROUND: The management of rectal cancer requires a multidisciplinary approach utilizing medical and surgical subspecialties. METHODS: We performed an investigation of patients with rectal adenocarcinoma from Los Angeles County from 1988 to 2006 using the Los Angeles County Cancer Surveillance Program. Clinical and pathologic characteristics were compared among groups and overall survival was stratified by race/ethnicity and SES. RESULTS: Of 9504 patients with rectal cancer, 53% (n = 4999) were white, 10% black, 18% Hispanic, and 14% Asian. Stratified by race/ethnicity, Asians had the best overall survival followed by Hispanics, whites, and blacks (median survival 7.7 vs. 5.7, 5.5, and 3.4 years, respectively; P < 0.001). Stratified by SES group, the highest group had the best overall survival followed by middle and lowest groups (median survival 8.4 vs. 5.1 and 3.8 years, respectively, P < 0.001). Similar results were observed for surgical patients. On multivariate analysis, race/ethnicity, and SES remained independent predictors of overall survival in patients with rectal adenocarcinoma. Furthermore, interaction analysis indicated that the improved survival for select racial/ethnic groups was not dependent on SES classification. CONCLUSIONS: Within the diverse Los Angeles County population, both race/ethnicity, and SES result in inequities in rectal cancer outcomes. Although SES may directly impact outcomes via access to care, the reasons for the association between race/ethnicity and outcomes remain uncertain.
OBJECTIVE: Because appropriate rectal cancer care and subsequent outcomes can be influenced by several variables, our objective was to investigate how race, ethnicity, and socioeconomic status (SES) may impact rectal cancer outcomes. BACKGROUND: The management of rectal cancer requires a multidisciplinary approach utilizing medical and surgical subspecialties. METHODS: We performed an investigation of patients with rectal adenocarcinoma from Los Angeles County from 1988 to 2006 using the Los Angeles County Cancer Surveillance Program. Clinical and pathologic characteristics were compared among groups and overall survival was stratified by race/ethnicity and SES. RESULTS: Of 9504 patients with rectal cancer, 53% (n = 4999) were white, 10% black, 18% Hispanic, and 14% Asian. Stratified by race/ethnicity, Asians had the best overall survival followed by Hispanics, whites, and blacks (median survival 7.7 vs. 5.7, 5.5, and 3.4 years, respectively; P < 0.001). Stratified by SES group, the highest group had the best overall survival followed by middle and lowest groups (median survival 8.4 vs. 5.1 and 3.8 years, respectively, P < 0.001). Similar results were observed for surgical patients. On multivariate analysis, race/ethnicity, and SES remained independent predictors of overall survival in patients with rectal adenocarcinoma. Furthermore, interaction analysis indicated that the improved survival for select racial/ethnic groups was not dependent on SES classification. CONCLUSIONS: Within the diverse Los Angeles County population, both race/ethnicity, and SES result in inequities in rectal cancer outcomes. Although SES may directly impact outcomes via access to care, the reasons for the association between race/ethnicity and outcomes remain uncertain.
Authors: Vanessa P Ho; Emily Steinhagen; Kelsey Angell; Suparna M Navale; Nicholas K Schiltz; Andrew P Reimer; Elizabeth A Madigan; Siran M Koroukian Journal: J Surg Res Date: 2017-11-09 Impact factor: 2.192
Authors: Leah L Zullig; William R Carpenter; Dawn Provenzale; Morris Weinberger; Bryce B Reeve; George L Jackson Journal: J Clin Oncol Date: 2013-09-03 Impact factor: 44.544
Authors: Jennifer M Knight; Karen L Syrjala; Navneet S Majhail; Michael Martens; Jennifer Le-Rademacher; Brent R Logan; Stephanie J Lee; Paul B Jacobsen; William A Wood; Heather S L Jim; John R Wingard; Mary M Horowitz; Muneer H Abidi; Mingwei Fei; Laura Rawls; J Douglas Rizzo Journal: Biol Blood Marrow Transplant Date: 2016-08-23 Impact factor: 5.742
Authors: Adil H Haider; Valerie K Scott; Karim A Rehman; Catherine Velopulos; Jessica M Bentley; Edward E Cornwell; Waddah Al-Refaie Journal: J Am Coll Surg Date: 2013-01-11 Impact factor: 6.113
Authors: Christina M Hester; Venkatakrishna R Jala; Morgan Gi Langille; Shahid Umar; K Allen Greiner; Bodduluri Haribabu Journal: World J Gastroenterol Date: 2015-03-07 Impact factor: 5.742
Authors: Tawnya L Bowles; Chung-Yuan Hu; Nancy Y You; John M Skibber; Miguel A Rodriguez-Bigas; George J Chang Journal: Dis Colon Rectum Date: 2013-05 Impact factor: 4.585